Embryonic
Stem Cell Research
Does Too Much Good to Be Evil.
Says Janet Rowley
U.S. News & World Report - Monday, March 23, 2009
Author: Janet Rowley The decision to end many restrictions on embryonic
stemcellresearch
has removed a key barrier to
research
and discovery. Scientists are driven by the desire to succeed as
fervently as our most success-driven businessmen, entrepreneurs,
or lawyers. But for years they have contended with research
limits that prevent innovation but do not serve a clear moral purpose. A responsible expansion of embryonic
stemcellresearch
can advance a vital goal — the search for new medical treatments — while respecting the dignity of human life.
At present, there are about 400,000 human embryos in the freezers of in vitro fertilization clinics. Many are destined
to be thawed and discarded and thus die. It is a true moral dilemma, but science offers a way to bring something good from
a flawed situation. The parents of these embryos could allow them to die, or they could donate the embryos for
research
that someday might benefit patients with incurable diseases. This is a high purpose, one that promotes both human health
and understanding.
Scientists have worked tirelessly to develop useful alternatives to these rare sources of embryonic
stemcells
. Through trial and error, they have developed a cocktail of genes that can transform adult human skin
cells
(from you and me) into
cells
closely resembling embryonic
stemcells
. But make no mistake — these are not embryonic
stemcells
. They are induced pluripotent
stemcells
.
The study of these
cells
is in its infancy. The hope is that induced pluripotent
cells
could be developed from individuals who have genetic disorders like juvenile
diabetes
, Parkinson's, and muscular dystrophy. Having
stemcells
with these defects could dramatically help scientists in their efforts to understand the basic, underlying problems
in
cells
with these mutations. That's because
stemcells
offer a unique window into
cell
development — and they can shed light on how development goes awry in serious diseases. However, investigators also
desperately need embryonic
stemcells
developed from patients with these genetic disorders to confirm that studies with induced pluripotent
cells
faithfully reproduce the genetic disorders. Scientists in the United States have developed such
cell
lines from embryos with genetic defects that were identified by genetic analyses. They have developed
cell
lines using money from private philanthropy because they have been prohibited by the previous administration from using
federal money to carry out this important
research
.
Today, scientists are free of this impediment. But like all
research
, work on
stemcells
needs firm ethical guidelines. That's why scientists have joined with ethicists, lawyers, and patient advocates to develop
the very strict rules that are currently in place to govern this area of study. I was part of a multidisciplinary group under
the auspices of the National Academy of Sciences that met numerous times to develop guidelines that help ensure such work
proceeds only within well-defined limits. The rules were adopted by California in 2005 to guide its
stemcell
initiative, and they have since been modified in response to California law and vigorous public debate.
One of the guiding principles in these policies is the intrinsic value of human life. The guidelines call for careful
ethical oversight of all
research
using human oocytes (eggs), embryos, or
cell
lines derived from these tissues. The
cells
and embryos must be obtained with informed consent, with no money paid for oocytes or embryos. All proposed
research
must be reviewed by a separate board that has scientists who are knowledgeable about embryonic
stemcellresearch
, as well as ethicists and the lay public. These representatives make certain that, for example, California's Institute
for Regenerative Medicine, a state agency created by a 2004
stemcellresearch
ballot referendum, supports only projects that advance knowledge and
specifically require the use of human embryos —
a high standard that ensures respect for human life. The embryos can be
cultured for only 12 days under California's rules,
meaning they never develop complex structure — a provision that many
ethicists believe is important to prevent future experimentation
on more mature embryos.
During this whole process of developing guidelines, scientists have been active and willing participants. Rather than
demanding to do their work unfettered, scientists realize that strict guidelines will enable our society, which is supporting
their work, to know that the
research
respects our shared values. Thus the scientific community now has many of the tools and resources needed to pursue
stemcellresearch
much more effectively than would have been possible only a few years ago.
As we work to refine guidelines, it is critical that the rules be
consistent between states, with national guidelines
most likely issued by the National Institutes of Health. It is
noteworthy that under President Bill Clinton, an eminent committee
chaired by Shirley Tilghman (now president of Princeton University)
wrote guidelines for NIH-funded stemcellresearch
. The guidelines were due to take effect in 2001, but their implementation was canceled by President George W. Bush.
Everyone benefits when science works with the political system, rather than being kept at the margins. At a time when
the promise and challenges of new technology are greater than ever, we need a national conversation driven by sound science
and our common values. Scientists don't expect to dictate all the rules for
stemcellresearch
or for any field with complex moral issues. But we should have a clear voice in the democratic exchange, to help ensure
that our
research
guidelines give us the best chance of finding new treatments and enriching life.
We've lost eight years; let's get started! Only by harnessing our intellectual and financial resources nationally will
we be able to realize the potential of
stemcells
as the therapeutic tool we all hope they will be.